Abstract:Abstract CD8 + cytotoxic T cells (CTLs) orchestrate antitumour immunity and exhibit inherent heterogeneity 1,2 , with precursor exhausted T (T pex ) cells but not terminally exhausted T (T ex ) cells capable of responding to existing immunotherapies 3–7 . The gene regulatory network that underlies CTL differentiation and whether T ex cell responses can be functionally reinvigorated are incompletely understood. Here we systematically mapped causal gene regulatory networks using single-cell CRISPR screens in vivo and discovered checkpoints for CTL differentiation. First, the exit from quiescence of T pex cells initiated successive differentiation into intermediate T ex cells. This process is differentially regulated by IKAROS and ETS1, the deficiencies of which dampened and increased mTORC1-associated metabolic activities, respectively. IKAROS-deficient cells accumulated as a metabolically quiescent T pex cell population with limited differentiation potential following immune checkpoint blockade (ICB). Conversely, targeting ETS1 improved antitumour immunity and ICB efficacy by boosting differentiation of T pex to intermediate T ex cells and metabolic rewiring. Mechanistically, TCF-1 and BATF are the targets for IKAROS and ETS1, respectively. Second, the RBPJ–IRF1 axis promoted differentiation of intermediate T ex to terminal T ex cells. Accordingly, targeting RBPJ enhanced functional and epigenetic reprogramming of T ex cells towards the proliferative state and improved therapeutic effects and ICB efficacy. Collectively, our study reveals that promoting the exit from quiescence of T pex cells and enriching the proliferative T ex cell state act as key modalities for antitumour effects and provides a systemic framework to integrate cell fate regulomes and reprogrammable functional determinants for cancer immunity.

The SWI/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8+ T cells

Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion

Developmental relationships of four exhausted CD8 T cell subsets reveals underlying transcriptional and epigenetic control mechanisms

Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation

BATF regulates progenitor to cytolytic effector CD8+ T cell transition during chronic viral infection

Selective control of transposable element expression during T cell exhaustion and anti–PD-1 treatment

Longitudinal single cell transcriptional and epigenetic mapping of effector, memory, and exhausted CD8 T cells reveals shared biological circuits across distinct cell fates

New epigenetic regulators of T cell exhaustion

Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control

Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer

MYB orchestrates T cell exhaustion and response to checkpoint inhibition

Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T cells toward durable effector-like states during chronic antigen exposure

Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy

The β 1 -adrenergic receptor links sympathetic nerves to T cell exhaustion

Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade

The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer

The SWI/SNF PBAF complex facilitates REST occupancy at repressive chromatin

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

BATF-mediated regulation of exhausted CD8+ T-cell responses and potential implications for chimeric antigen receptor-T therapy

Fundamentals to therapeutics: Epigenetic modulation of CD8+ T Cell exhaustion in the tumor microenvironment